IκB/IKK
IKK (IκB kinase) is an enzyme complex that participates in NF-κB signaling pathway. It phosphorylates and inhibits IκB, thus leads to the activation of NF-κB. It is a target for treatment of inflammatory diseases and cancer.
Products for IκB/IKK
- Cat.No. Product Name Information
-
GC66334
(Rac)-PF-184 hydrate
(Rac)-PF-184 hydrate is a potent inhibitory factor-κB kinase 2 (IKK-2) inhibitor with an IC50 of 37 nM. (Rac)-PF-184 hydrate has anti-inflammatory effects.
-
GC74339
Ac2-26 ammonium
Ac2-26 ammonium is the N-terminal peptide of annexin 1, and has anti-inflammatory activity.
-
GC17416
ACHP
IκB kinase inhibitor
-
GC31319
Amlexanox (AA673)
AA 673, CHX 3673, Elics
Amlexanox (AA673) (AA673; Amoxanox; CHX3673) is a specific inhibitor of IKKε and TBK1, and inhibits the IKKε and TBK1 activity determined by MBP phosphorylation with an IC50 of approximately 1-2 μM. -
GN10718
Andrographolide
-
GC10135
AZD3264
IKK2 inhibitor
-
GC10345
Bay 11-7085
NK-κB activation inhibitor
-
GC13035
Bay 11-7821
BAY 11-7082
Bay 11-7821(BAY 11-7082) is an inhibitor of IκBα phosphorylation and NF-κB, selectively and irreversibly inhibits TNF-α-induced IκB-α phosphorylation (IC50 value is approximately 10μM), and reduces the expression of NF-κB and adhesion molecules. Bay 11-7821 inhibits ubiquitin-specific proteases USP7 and USP21 with IC50 values of 0.19 and 0.96μM, respectively . -
GC35474
Bay 65-1942 free base
Bay 65-1942 free base is an ATP-competitive and selective IKKβ inhibitor.
-
GC16303
Bay 65-1942 HCl salt
-
GC35475
Bay 65-1942 R form
Bay 65-1942 R form is the less active R-form of Bay 65-1942.
-
GC60624
BAY-985
A dual inhibitor of TBK1 and IKKε
-
GC18200
BI-605906
BI-605906 is an inhibitor of inhibitor of kappa B kinase subunit β (IKKβ; IC50 = 380 nM).
-
GC19069
BI605906
BI605906 is a novel IKKβ inhibitor with an IC50 value of 380 nM when assayed at 0.1 mM ATP.
-
GC32028
BMS-066
BMS-066 is an IKKβ/Tyk2 pseudokinase inhibitor, with IC50s of 9 nM and 72 nM, respectively.
-
GC13926
BMS-345541(free base)
BMS-345541(free base) is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM). BMS-345541(free base) binds at an allosteric site of IKK.
-
GC12399
BMS345541 hydrochloride
IKK Inhibitor III
A selective inhibitor of IKKα and IKKβ -
GC15083
Celastrol
Celastrol is a proteasome inhibitor with a potent and preferred inhibition of purified 20S proteasome with an IC50 of 2.5 μM.
-
GC35674
Chicanine
Chicanine is a lignan compound of Schisandra chinesis, inhibits LPS-induced phosphorylation of p38 MAPK, ERK 1/2 and IκB-α, with anti-inflammatory activity.
-
GC11170
Choline Fenofibrate
-
GC17873
CID-2858522
CID 2858522;CID2858522
A selective inhibitor of NF-κB activation -
GC16044
Emodin
Archin, Frangulic Acid, NSC 408120, NSC 622947, Schuttgelb
Natural CK2 inhibitor and ER agonist -
GC33816
Ertiprotafib (PTP 112)
PTP 112
Ertiprotafib (PTP 112) is an inhibitor of PTP1B, IkB kinase β (IKK-β), and a dual PPARα and PPARβ agonist, with an IC50 of 1.6 μM for PTP1B, 400 nM for IKK-β, an EC50 of ~1 μM for PPARα/PPARβ. -
GC20007
Ginsenoside CK
Ginsenoside Compound K, Ginsenoside IH901; Compound K
Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively.
-
GC43786
GS-143
GS-143 is an inhibitor of IκBα ubiquitylation.
-
GC65013
GSK8612
GSK8612 is a highly selective and potent Tank-binding Kinase-1 (TBK1) inhibitor, with a pIC50 of 6.8 for recombinant TBK1.
-
GC62161
HOIPIN-1
JTP-0819958
HOIPIN-1 (JTP-0819958) is a selective linear ubiquitin chain assembly complex (LUBAC) inhibitor with an IC50 of 2.8 μM. HOIPIN-1 suppress LUBAC-mediated NF-kB activation in vitro. -
GN10664
Honokiol
NSC 293100
Honokiol is a natural bisphenol chemical with multiple biological activities. It targets multiple signaling molecules and has effective antioxidant, anti-inflammatory, anti-angiogenic and anti-cancer activities. It also has broad-spectrum antibacterial and anti-human immunodeficiency virus (HIV) activities. -
GC63007
HPN-01
HPN-01 is a potent and selective IKK inhibitor, with pIC50 values of 6.4, 7.0 and <4.8 for IKK-α, IKK-β and IKK-ε, respectively.
-
GC12370
IKK-16 (hydrochloride)
IKK Inhibitor VII
IκB kinases (IKKs) inhibitor -
GC12180
IKK-16 (IKK Inhibitor VII)
IKK-16 (IKK Inhibitor VII) is a selective IκB kinase (IKK) inhibitor for IKK2, IKK complex and IKK1 with IC50s of 40 nM, 70 nM and 200 nM, respectively.
-
GC11508
IKK-2 inhibitor VIII
-
GC10592
IKK-3 Inhibitor
GSK 319347A
A multi-kinase inhibitor -
GC13278
IKKε-IN-1
potent IKKε inhibitor
-
GC17830
IMD 0354
IKK2 Inhibitor V
IKKβ inhibitor -
GC33306
IMD-0560
IMD-0560 is a novel IκB kinase β inhibitor.
-
GC34907
INH14
INH14 is a cell permeable inhibitor of IKKα/IKKβ, with IC50s of 8.97 and 3.59 μM, respectively.
-
GN10370
Luteolin
Luteolin is a flavonoid compound with multiple functions such as anti-inflammatory, antioxidant, and anti-cancer. Luteolin is an effective inhibitor of nuclear factor erythroid 2-related factor 2 (Nrf2).
-
GC10093
LY2409881
LY2409881 is a selective IκB kinase β (IKK2) inhibitor with an IC50 of 30 nM.
-
GC61021
Malachite green oxalate
Malachite green oxalate is a triphenylmethane dye which can be used to detect the release of phosphate in enzymatic reactions. Malachite green oxalate is also a potent and selective inhibitor of IKBKE, and inhibits its downstream targets such as IκBα, p65 and IRF3. Malachite green oxalate exhibits antitumor activity in vitro and in vivo.
-
GC15942
ML 120B dihydrochloride
IKK2-selective inhibitor
-
GC14989
MLN120B
An IKKβ inhibitor
-
GC66019
MLN120B dihydrochloride
ML120B dihydrochloride
MLN120B dihydrochloride (ML120B dihydrochloride) is a potent, ATP competitive, and orally active inhibitor of IKKβ with an IC50 of 60 nM. MLN120B inhibits multiple myeloma cell growth in vitro and in vivo and also can be used for the research of rheumatoid arthritis. -
GC50093
MRT 68601 hydrochloride
Potent TBK inhibitor
-
GC17136
MRT67307
A kinase inhibitor
-
GC13184
PF 184
PF 184 is a potent inhibitory factor-κB kinase 2 (IKK-2) inhibitor with an IC50 of 37 nM.
-
GC67890
PHA 408
-
GN10503
Piceatannol
Astringenin, transPicetannol, trans3,3',4,5'Tetrahydroxystilbene
Piceatannol (3,3′,4,5′-trans-trihydroxystilbene) is a naturally occurring hydroxylated analogue of resveratrol. -
GC12609
PS 1145 dihydrochloride
IκB kinase (IKK) inhibitor
-
GC17603
PS-1145
IKK Inhibitor X
IKK inhibitor -
GC11751
QNZ (EVP4593)
CAY10470
An inhibitor of NF-κB activation -
GC14553
Resveratrol
(E)Resveratrol
Resveratrol (trans-Resveratrol; SRT501) is a phytoalexin. -
GC12372
SC-514
GK 01140
ATP-competitive IKK-2 inhibitor, orally active -
GC10933
Sodium 4-Aminosalicylate
Sodium 4-Aminosalicylate (4-Aminosalicylic acid sodium salt dihydrate) is one of the antimycobacterial drugs currently used for multidrug-resistant tuberculosis.
-
GC12013
Sodium salicylate
NF-κB inhibitor
-
GN10737
Tanshinone IIA
NSC 686518, NSC 686519, TSA
Tanshinone IIA is a major tanshinone isolated from Salvia divinorum. Commonly used in cardiovascular disease and cancer research. -
GC69998
TBK1-IN-1
TBK1-IN-1 is an effective selective inhibitor of TANK-binding kinase 1 (TBK1), with an IC50 value of 22.4 nM. TBK1-IN-1 inhibits the expression of downstream target genes cxcl10 and ifnβ of TBK1. TBK1-IN-1 has anti-cancer activity.
-
GC37747
TBK1/IKKε-IN-1
TBK1/IKKε-IN-1 is a dual TBK1 and IKKε inhibitor extracted from patent US20160376283 A1, Compound 274 in Example 60, has IC50s of <100 nM.
-
GC63212
TBK1/IKKε-IN-4
TBK1/IKKε-IN-4 is a 6-aminopyrazolopyrimidine derivative and a potent, selective TBK1 and IKKε inhibitor with IC50 values of 13 nM and 59 nM, respectively. TBK1/IKKε-IN-4 shows 100- to 1000-fold less activity against other protein kinases including PDK1, PI3K family members and mTOR.
-
GC37748
TBK1/IKKε-IN-5
TBK1/IKKε-IN-5 (compound 1) is an orally active TBK1 and IKKε dual inhibitor, with IC50 values of 1 and 5.6 nM, respectively. TBK1/IKKε-IN-5 enhances the blockade response to PD-1 and induces immune memory in rats when combines with anti-PD-L1. TBK1/IKKε-IN-5 can be used in cancer research, especially in tumour immunity.
-
GC16658
Vinpocetine
Apovincaminic Acid ethyl ester, AY 27255, RGH-4405
PDE inhibitor -
GN10269
Wedelolactone
IKK Inhibitor II
-
GC13384
WS6
inducer of β cell proliferation